C-kit is a specific surface markers of CSCs . In myocardium after AMI,the density of c-kit+CSCs and c-kit expression are increased significantly,which is a good repair effect to the injury of the myocardium. Our preliminary experiments show SDF-1 can increase the surface expression of c-kit,and the methylation differences between c-kit-CSCs and c-kit+CSCs are significant. However,its precise mechanism is unknown. This project intends to①transfecting plasmid DNMT and DNMT-siRNA plasmid into CSCs, observation on c-kit,DNMT expression and so on. ②CSCs is intervented by SDF-1 ,and ade in LY294002,which is specific inhibitor of PI3K / Akt signaling pathway,observation on c-kit,DNMT, phosphorylated Akt expression,and so on. ③CSCs which is intervented by SDF-1 and LY294002 are transplanted into the c-kit gene knockout models of AMI rat myocardium,observation on myocardial infarct size, heart function and c-kit, DNMT expression. Demonstration of PI3K / AKT signaling pathway activation results in DNMT reduction,c-kit gene hypomethylation, and the expression of c-kit increased, then enhance migration ability,proliferation ability of CSCs,and the regeneration and repair of cardiac injury potential. This study perspective to explore the effect of c-kit to CSCs and the related molecular mechanism, for the treatment of ischemic heart disease with a new target.
c-kit是心肌干细胞(CSCs)特异性表面标志,心梗后c-kit表达增高,对损伤心肌有修复作用。我们的前期试验显示基质细胞衍生因子-1(SDF-1)能上调CSCs表面c-kit表达;c-kit+与c-kit-CSCs存在明显甲基化差异。但机制不明。本课题拟①将DNMT质粒及DNMT-siRNA质粒转染CSCs,观察c-kit、DNA甲基转移酶(DNMT)表达②SDF-1及PI3K/Akt信号通路特异性抑制剂LY294002干预CSCs,观察DNMT、磷酸化Akt表达③将SDF-1及LY294002干预的CSCs移植入心梗模型大鼠心肌内,观察心梗面积、心功能及c-kit、DNMT表达。论证PI3K/AKT信号通路激活致DNMT减少,使c-kit基因低甲基化,c-kit表达增加,增强CSCs迁移、增殖潜能。本研究探索c-kit基因表达对CSCs影响及分子机制,为缺血性心脏病的治疗提供新靶点。
CPCs 能自我更新并且可以自发的增殖分化为心肌细胞、平滑肌细胞和内皮细胞等,能够程序性地重建心脏。探索基质细胞衍生因子-1α(SDF-1α)影响小鼠心肌祖细胞(CPCs)c-kit基因表达的相关机制研究。从小鼠心肌中分离培养出CPCs,并用免疫磁珠法筛选出c-kit+和c-kit- CPCs。使用不同浓度的SDF-1α干预c-kit+ 和c-kit- CPCs 不同时间,Western blot法检测c-kit蛋白的表达,qPCR观察c-kit mRNA的表达。然后用SDF-1α和AMD3100干预c-kit+ 和c-kit- CPCs后,CCK-8试剂盒检测细胞增殖能力, Transwell 小室检测细胞迁移能力。最后用SDF-1α和AMD3100干预c-kit+ 和c-kit- CPCs后,qPCR检测DNA甲基转移酶 ( DNMT) mRNA的表达,DNMT活性检测试剂盒检测DNMT的活性,基质辅助激光解吸附电离飞行时间质谱分析技术检测DNA甲基化水平。结果 消化后的心肌组织块经过10天左右的培养,可见小、圆、亮的细胞出现在组织块周围爬出的成纤维细胞层上。流式细胞分析显示经过磁珠分选后c-kit+ CPCs c-kit阳性率为 82.06%,Sca-1阳性率为82.87%。Western blot及qPCR结果显示SDF-1α干预后c-kit+ CPCs c-kit蛋白及mRNA表达均显著增加,c-kit- CPCs c-kit蛋白及mRNA从阴性转为阳性,并且均呈浓度及时间依赖性,AMD3100可以拮抗SDF-1α对c-kit表达的影响。SDF-1α干预后c-kit+ 和c-kit- CPCs增殖和迁移能力较对照组显著增加。最后,SDF-1α可以抑制DNMT1、DNMT3β mRNA的表达以及DNMT活性,并且导致c-kit基因发生去甲基化。因此,SDF-1α可以通过抑制DNMTs的表达与活性,下调c-kit基因启动子区CpG岛的甲基化水平,从而提高c-kit基因的表达,促进CPCs的增殖和迁移能力。
{{i.achievement_title}}
数据更新时间:2023-05-31
DNAgenie: accurate prediction of DNA-type-specific binding residues in protein sequences
神经退行性疾病发病机制的研究进展
"多对多"模式下GEO卫星在轨加注任务规划
基于SSR 的西南地区野生菰资源 遗传多样性及遗传结构分析
MK-FSVM-SVDD: A Multiple Kernel-based Fuzzy SVM Model for Predicting DNA-binding Proteins via Support Vector Data Description
SDF-1对心脏干细胞c-kit基因DNA甲基化调控的机制研究
阿托伐他汀提高c-kit(+)心肌干细胞治疗急性心肌梗死的疗效及其机制
人类白血病的C-Kit受体及其配体基因表达和调控研究
Exosome介导干细胞组蛋白甲基化调控心肌重构的研究